Preparation and characterization of pioglitazone cyclodextrin inclusion complexes

Journal of Young Pharmacists

Volumn 3, Issue 4, 2011, Pages 267-274

  Pandit, V ^a   Gorantla, R ^a   Devi, K ^a   Pai, R S ^a   Sarasija, S ^b  

^a AL AMEEN COLLEGE OF PHARMACY   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Inclusion complexes; methyl cyclodextrin; phase solubility; pioglitazone; solubility; spray drying

Indexed keywords

BETA CYCLODEXTRIN; CYCLODEXTRIN; GAMMA CYCLODEXTRIN; METHYL BETA CYCLODEXTRIN; PIOGLITAZONE;

ARTICLE; COMPLEX FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; DRUG MIXTURE; DRUG SOLUBILITY; DRUG STABILITY; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; PHASE TRANSITION; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STOICHIOMETRY; X RAY POWDER DIFFRACTION;

EID: 82955228962     PISSN: 09751483     EISSN: 09751505     Source Type: Journal    
DOI: 10.4103/0975-1483.90234     Document Type: Article

References (16)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
2. Available from: http://www.who.int/mediacentre/factsheets/fs312/en/index. html. cited on 2010 Oct 14.
3. Grossman L. New solutions for type 2 diabetes mellitus the role of pioglitazone. Pharmacoeconomics 2002;20(Suppl 1):1-9. (Pubitemid 34564433)
4. Reginato MJ, Lazar MA. Mechanisms by which Thiazolidinediones enhance insulin action. Trends Endocr Metab 1999;10:9-13. (Pubitemid 29288704)
5. Gillies PS, Dunn CJ. Pioglitazone. Drugs 2000;60:333-43.
6. Jouyban A, Soltanpour S. Solubility of pioglitazone hydrochloride in binary mixtures of polyethylene glycol 400 with ethanol, propylene glycol, N-methyl-2-pyrrolidone, and water at 25°C. Chem Pharm Bull 2010;55:1132-5.
7. Hiremath SN, Raghavendra RK, Sunil F, Danki LS, Rampure MV, Swamy PV, et al. Dissolution enhancement of gliclazide by preparation of inclusion complexes with β-cyclodextrin. Asian J Pharm 2008;2:73-6.
8. Knoerr AL, Gref R, Couvreur P. Cyclodextrins for drug delivery. J Drug Targeting 2010;18:1-12.
9. Higuchi T, Connors KA. Phase solubility techniques. Adv Anal Chem Instrum 1965;4:117-212.
10. Asker AF, Whitworth CW. Dissolution of acetyl salicylic acid from acetyl salicylic acid-polyethylene glycol 6000 coprecipitates. Pharmazie 1975;30:530-1.
11. Doiphode D, Gaikwad S, Pore Y, Kuchekar B, Late S. Effect of β-cyclodextrin complexation on physicochemical properties of zaleplon. J Inclusion Phenom Macrocyclic Chem 2008;62:43-50.
12. Wong JW, Yuen KH. Inclusion Complexation of Artemisinin with α-, β-, and γ-Cyclodextrins. Drug Dev Ind Pharm 2003;29:1035-44.
13. Patel RP, Patel MM. Preparation and evaluation of inclusion complex of lipid lowering drug lovastatin with-Cyclodextrins. Drug Dev Ind Pharm 2003;29:1035-44.
14. Patel RP, Patel MM. Preparation and evaluation of inclusion complex of lipid lowering drug lovastatin with β-cyclodextrin. Dhaka Univ J Pharm Sci 2007;6:25-36. (Pubitemid 47342677)
15. Patil JS, Kadam DV, Marapur SC, Kamalapur MV. Inclusion complex system: A novel technique to improve the solubility and bioavailability of poorly soluble drugs: A review. Int J Pharm Sci Rev Res 2010;2:29-34.
16. Valle Del EM. Cyclodextrins and their uses: A review. Process Biochem 2004;39:1033-46.